Growth Factors , Cytokines , Cell Cycle Molecules The Neuronal Expression of MYC Causes a Neurodegenerative Phenotype in a Novel Transgenic Mouse

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal binucleation in Alzheimer disease hippocampus

  2008cited by this paper
• Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.

  2008cited by this paper
• Neuronal cell cycle re-entry mediates Alzheimer disease-type changes.

  2007cited by this paper
• The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development.

  2007cited by this paper
• BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease

  2007cited by this paper
• Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease

  2007cited by this paper
• Conditional Neuronal Simian Virus 40 T Antigen Expression Induces Alzheimer-Like Tau and Amyloid Pathology in Mice

  2007cited by this paper
• Oncogenic parallels in Alzheimer disease

  2006cited by this paper
• Modafinil-induced modulation of working memory and plasma corticosterone in chronically-stressed mice.

  2006cited by this paper
• Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.

  2006cited by this paper
• Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.

  2005cited by this paper
• Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP‐1‐associated regulator of cyclin B, in Alzheimer's disease

  2004cited by this paper
• MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

  2004cited by this paper
• Expression Patterns of Retinoblastoma Protein in Parkinson Disease

  2003cited by this paper
• Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis.

  2003cited by this paper
• Proteolysis, free radicals, and aging.

  2002cited by this paper
• Phosphorylated c‐MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

  2001influential reference
• SOD1 Down-Regulates NF-κB and c-Myc Expression in Mice after Transient Focal Cerebral Ischemia

  2001cited by this paper
• DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease

  2001cited by this paper
• Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment.

  2000cited by this paper
• N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease.

  2000cited by this paper
• Reversible tumorigenesis by MYC in hematopoietic lineages.

  1999cited by this paper
• Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death*

  1999cited by this paper
• Hippocampal Myc and p53 expression following transient global ischemia.

  1998cited by this paper
• Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain

  1997cited by this paper
• Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions

  1997cited by this paper
• Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

  1997cited by this paper
• Up-regulation of c-myc gene expression following focal ischemia in the rat brain.

  1996cited by this paper
• Control of Memory Formation Through Regulated Expression of a CaMKII Transgene

  1996cited by this paper
• Subregion- and cell type-restricted gene knockout in mouse brain.

  1996cited by this paper
• Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.

  1995cited by this paper
• Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice.

  1992cited by this paper
• Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice.

  1992cited by this paper
• Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons.

  1989cited by this paper

• Human Brain Organoids: A New Model to Study Cryptococcus neoformans Neurotropism

  2025cites this paper
• Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's disease

  2025cites this paper
• FMRP regulation of STAT3-MYC signaling is critical for adult hippocampal neurogenesis and cognitive flexibility

  2025cites this paper
• Transcriptomic analysis reinforces the implication of spatacsin in neuroinflammation and neurodevelopment

  2025cites this paper
• Brain Plasticity and Cell Competition: Immediate Early Genes Are the Focus

  2025cites this paper
• Uncovering potential molecular markers and pathological mechanisms of Parkinson's disease and myocardial infarction based on bioinformatics analysis

  2025cites this paper
• MYC: there is more to it than cancer

  2024cites this paper
• Somatic mutations in Alzheimer-associated tetraploid neurons

  2024cites this paper
• Distinct Transcriptomic Responses to Aβ plaques, Neurofibrillary Tangles, and APOE in Alzheimer’s Disease

  2023cites this paper
• Interactome analysis implicates class II transactivator (CIITA) in depression and other neuroinflammatory disorders

  2023cites this paper
• Distinct transcriptomic responses to Aβ plaques, neurofibrillary tangles, and APOE in Alzheimer's disease

  2023cites this paper
• Emerging Roles of Signal Transduction Pathways in Neurodegenerative Diseases. Hunting New Possible Therapeutic Molecular Targets

  2023cites this paper
• PSINDB: the postsynaptic protein–protein interaction database

  2022cites this paper
• E2F4DN Transgenic Mice: A Tool for the Evaluation of E2F4 as a Therapeutic Target in Neuropathology and Brain Aging

  2022cites this paper
• Neurons and glial cells acquire a senescent signature after repeated mild traumatic brain injury in a sex-dependent manner

  2022cites this paper
• Oncogenic Pathways in Neurodegenerative Diseases

  2022cites this paper
• Exercise Training-Increased FBXO32 and FOXO1 in a Gender-Dependent Manner in Mild Cognitively Impaired African Americans: GEMS-1 Study

  2021cites this paper
• E2F4-Based Gene Therapy Mitigates the Phenotype of the Alzheimer’s Disease Mouse Model 5xFAD

  2021cites this paper
• Metabolism navigates neural cell fate in development, aging and neurodegeneration

  2021cites this paper
• Whole Blood Transcriptome Characterization of 3xTg-AD Mouse and Its Modulation by Transcranial Direct Current Stimulation (tDCS)

  2021cites this paper
• Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice

  2021cites this paper
• MicroRNA-146a inhibition promotes total neurite outgrowth and suppresses cell apoptosis, inflammation, and STAT1/MYC pathway in PC12 and cortical neuron cellular Alzheimer's disease models

  2021cites this paper
• Regulatory miRNA–mRNA Networks in Parkinson’s Disease

  2021cites this paper
• Bridging the Metabolic Parallels Between Neurological Diseases and Cancer.

  2021cites this paper
• Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair

  2021cites this paper
• Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division.

  2021cites this paper
• Pathological Aspects of Neuronal Hyperploidization in Alzheimer’s Disease Evidenced by Computer Simulation

  2020cites this paper
• Treatment of Neuroblastoma Cells with Inhibitors of Protein Disulfide Isomerase Upregulates NQO1 Activity.

  2020cites this paper
• Gliosis Precedes Amyloid-β Deposition and Pathological Tau Accumulation in the Neuronal Cell Cycle Re-Entry Mouse Model of Alzheimer’s Disease

  2020cites this paper
• Cell cycle re-entry of neurons and reactive neuroblastosis in Huntington's disease: Possibilities for neural-glial transition in the brain.

  2020cites this paper
• Marine bacterial extracts as a new rich source of drugs against Alzheimer’s disease

  2020cites this paper
• QUANTITATIVE SUBCELLULAR PROTEOMICS OF THE ORBITOFRONTAL CORTEX OF SCHIZOPHRENIA PATIENTS.

  2019cites this paper
• DNA methylation variability in Alzheimer's disease.

  2019cites this paper
• Neuropathology-driven Whole-genome Sequencing Study Points to Novel Candidate Genes for Healthy Brain Aging

  2019cites this paper
• Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.

  2019cites this paper
• Normal aging hyperactivates innate immunity and reduces the medical efficacy of minocycline in brain injury.

  2019cites this paper
• Omics and Epigenetics of Polyphenol-Mediated Neuroprotection: The Curcumin Perspective

  2019cites this paper
• Small Molecule Inhibition of Protein Disulfide Isomerase in Neuroblastoma Cells induces Oxidative Stress Response and Apoptosis Pathways.

  2019cites this paper
• Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer’s Disease and Brain Insulin Resistance, and Its Relation to Cancer

  2018cites this paper
• Tau/DDX6 interaction increases microRNA activity.

  2018cites this paper
• Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.

  2018cites this paper
• The Potential Protective Effect of Curcumin on Amyloid-β-42 Induced Cytotoxicity in HT-22 Cells

  2018cites this paper
• MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease

  2017cites this paper
• Cell-cycle Alterations in Post-mitotic Cells and Cell Death by Mitotic Catastrophe

  2016cites this paper
• The amyloid cascade hypothesis: are we poised for success or failure?

  2016cites this paper
• Differential DNA Methylation of MicroRNA Genes in Temporal Cortex from Alzheimer's Disease Individuals Journal Issue:

  2016cites this paper
• Differential DNA Methylation of MicroRNA Genes in Temporal Cortex from Alzheimer's Disease Individuals

  2016cites this paper
• Title Differential DNA Methylation of MicroRNA Genes in Temporal Cortex from Alzheimer ' s Disease Individuals Permalink

  2016cites this paper
• RESTRICTION OF APOPTOSIS IN MATURE NEURONS BY MULTIPLE REDUNDANT BRAKES

  2016cites this paper
• Ethanol-induced changes in poly (ADP ribose) polymerase and neuronal developmental gene expression.

  2016cites this paper
• Late phase cell cycle proteins in Alzheimer’s disease: a possible target for therapy?

  2016cites this paper
• Oxidative Stress and Aberrant Cell Cycle in Alzheimer’s Disease Lymphocytes: Diagnostic Prospects

  2015cites this paper
• Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease

  2015cites this paper
• In vitro and in vivo characterization of the E3 ubiquitin ligase RNF157 in the brain

  2015cites this paper
• Social Eavesdropping in Zebrafish

  2015cites this paper
• DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells

  2015cites this paper
• Brain Transcriptomic Response to Social Eavesdropping in Zebrafish (Danio rerio)

  2015cites this paper
• Thesis committee members

  2014cites this paper
• Distinct Chronology of Neuronal Cell Cycle Re-Entry and Tau Pathology in the 3xTg-AD Mouse Model and Alzheimer's Disease Patients

  2014cites this paper
• Efficacy of Cyclin Dependent Kinase 4 Inhibitors as Potent Neuroprotective Agents against Insults Relevant to Alzheimer’s Disease

  2013cites this paper
• FoxO3a is activated and executes neuron death via Bim in response to β-amyloid

  2013cites this paper
• Differential Roles for the Retinoblastoma Protein in Cycling and Quiescent Neural Populations

  2013cites this paper
• Abortive Cell Cycle Events in the Brains of Scrapie-Infected Hamsters with Remarkable Decreases of PLK3/Cdc25C and Increases of PLK1/Cyclin B1

  2013cites this paper
• Control of vertebrate development by MYC.

  2013cites this paper
• SRPK2 Phosphorylates Tau and Mediates the Cognitive Defects in Alzheimer's Disease

  2012cites this paper
• Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.

  2012cites this paper
• PRPC AND CELL CYCLE RE-ENTRY: A NOVEL PATHOGENIC MECHANISM FOR Aβ NEUROTOXICITY

  2012influential citation
• Delineating the Role of c-Myc in Development and Propagation of Hypertrophic Cardiomyopathy

  2012cites this paper
• Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity

  2012cites this paper
• The protective effect of curcumin on Aβ induced aberrant cell cycle reentry on primary cultured rat cortical neurons.

  2012cites this paper
• Cellular prion protein is essential for oligomeric amyloid-b-induced neuronal cell death

  2012cites this paper
• Strategic Role for Mitochondria in Alzheimer's Disease and Cancer

  2012cites this paper
• Activity-and pharmacology-dependent modulation of adult neurogenesis in relation to Alzheimer’s disease

  2012cites this paper
• Activity- and pharmacology-dependent modulation of adult neurogenesis in relation to Alzheimer’s disease

  2012cites this paper
• Animal Models of Alzheimer's Disease

  2011cites this paper
• arly induction of c-Myc is associated with neuronal cell death

  2011cites this paper
• Genetic Risk Factors: Their Function and Comorbidities in Alzheimer's Disease

  2011cites this paper
• The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies

  2011cites this paper
• Deciphering the intricate regulatory mechanisms for the cellular choice between cell repair, apoptosis or senescence in response to damaging signals.

  2011cites this paper
• Cell cycle deregulation in the neurons of Alzheimer's disease.

  2011cites this paper
• Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration

  2011cites this paper
• Cell cycle reactivation in mature neurons: a link with brain plasticity, neuronal injury and neurodegenerative diseases?

  2011cites this paper
• c-Myc induction of programmed cell death may contribute to carcinogenesis

  2011cites this paper
• MithramycinIsaGene-SelectiveSp1InhibitorThat IdentifiesaBiologicalIntersectionbetweenCancerand Neurodegeneration

  2011cites this paper
• Pathological implications of cell cycle re-entry in Alzheimer disease

  2010cites this paper
• Neuronal Models for Studying Tau Pathology

  2010cites this paper
• Mitotic Epitopes are Incorporated into Age‐dependent Neurofibrillary Tangles in Niemann–Pick Disease Type C

  2010cites this paper
• Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis

  2010cites this paper
• Neurogenesis and Alzheimer's disease: Biology and pathophysiology in mice and men.

  2010cites this paper
• Biomarkers in Alzheimer's disease: past, present and future.

  2010cites this paper
• Cell cycle and Alzheimer's disease: studies in non-neuronal cells

  2010cites this paper
• Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain

  2010cites this paper
• CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease

  2010cites this paper
• Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration.

  2010cites this paper
• The power of reversibility regulating gene activities via tetracycline-controlled transcription.

  2010cites this paper
• All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease

  2009cites this paper
• Cell cycle aberrations in Alzheimer’s disease: a novel therapeutic opportunity

  2009cites this paper
• The Question of Cell Cycle Reentry by Mature Neurons in Response to Amyloid-β and Tau Pathology

  2009cites this paper
• Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease

  2009cites this paper
• The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease

  2009cites this paper